InvestorsHub Logo
Followers 0
Posts 46
Boards Moderated 0
Alias Born 02/02/2015

Re: greenwillow post# 5145

Wednesday, 08/01/2018 8:57:09 PM

Wednesday, August 01, 2018 8:57:09 PM

Post# of 6315
Admittedly, the granting of Epidiolex was good news for the industry and NMUS.

However, Zynerba was getting approved in 2016 and 2017 when NMUS was ostensibly getting rejected.

I just think it reflects poorly to go to the FDA with the same argument. Surely there could be another approach - or at least an explanation. Murphy had an interview not long ago and he failed to describe anything new. He just harped on the same UM and "medical indications of unmet medical need" tropes.